{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T17:28:14Z","timestamp":1793381294430,"version":"4.5.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,7,26]],"date-time":"2022-07-26T00:00:00Z","timestamp":1658793600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,7,26]],"date-time":"2022-07-26T00:00:00Z","timestamp":1658793600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","award":["CH\/12\/4\/29762"],"award-info":[{"award-number":["CH\/12\/4\/29762"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","award":["RE\/18\/6\/34217"],"award-info":[{"award-number":["RE\/18\/6\/34217"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Biol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Hyperaldosteronism causes cardiovascular disease as well as hypomagnesemia. Mechanisms are ill-defined but dysregulation of TRPM7, a Mg<jats:sup>2+<\/jats:sup>-permeable channel\/\u03b1-kinase, may be important. We examined the role of TRPM7 in aldosterone-dependent cardiovascular and renal injury by studying aldosterone-salt treated TRPM7-deficient (TRPM7<jats:sup>+\/\u0394kinase<\/jats:sup>) mice. Plasma\/tissue [Mg<jats:sup>2+<\/jats:sup>] and TRPM7 phosphorylation were reduced in vehicle-treated TRPM7<jats:sup>+\/\u0394kinase<\/jats:sup> mice, effects recapitulated in aldosterone-salt-treated wild-type mice. Aldosterone-salt treatment exaggerated vascular dysfunction and amplified cardiovascular and renal fibrosis, with associated increased blood pressure in TRPM7<jats:sup>+\/\u0394kinase<\/jats:sup> mice. Tissue expression of Mg<jats:sup>2+<\/jats:sup>-regulated phosphatases (PPM1A, PTEN) was downregulated and phosphorylation of Smad3, ERK1\/2, and Stat1 was upregulated in aldosterone-salt TRPM7-deficient mice. Aldosterone-induced phosphorylation of pro-fibrotic signaling was increased in TRPM7<jats:sup>+\/\u0394kinase<\/jats:sup> fibroblasts, effects ameliorated by Mg<jats:sup>2+<\/jats:sup> supplementation. TRPM7 deficiency amplifies aldosterone-salt-induced cardiovascular remodeling and damage. We identify TRPM7 downregulation and associated hypomagnesemia as putative molecular mechanisms underlying deleterious cardiovascular and renal effects of hyperaldosteronism.<\/jats:p>","DOI":"10.1038\/s42003-022-03715-z","type":"journal-article","created":{"date-parts":[[2022,7,26]],"date-time":"2022-07-26T08:02:58Z","timestamp":1658822578000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["TRPM7 deficiency exacerbates cardiovascular and renal damage induced by aldosterone-salt"],"prefix":"10.1038","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8194-0787","authenticated-orcid":false,"given":"Francisco J.","family":"Rios","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Guo","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2845-4982","authenticated-orcid":false,"given":"Adam P.","family":"Harvey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katie Y.","family":"Harvey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7451-7147","authenticated-orcid":false,"given":"Livia L.","family":"Camargo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5158-9263","authenticated-orcid":false,"given":"Karla B.","family":"Neves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6976-3714","authenticated-orcid":false,"given":"Sarah E. F.","family":"Nichol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rheure","family":"Alves-Lopes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexius","family":"Cheah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maram","family":"Zahraa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexey G.","family":"Ryazanov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lillia","family":"Ryazanova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0323-7965","authenticated-orcid":false,"given":"Thomas","family":"Gudermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6042-4193","authenticated-orcid":false,"given":"Vladimir","family":"Chubanov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Augusto C.","family":"Montezano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0670-0887","authenticated-orcid":false,"given":"Rhian M.","family":"Touyz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,7,26]]},"reference":[{"key":"3715_CR1","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1161\/HYPERTENSIONAHA.119.12935","volume":"74","author":"JW Funder","year":"2019","unstructured":"Funder, J. W. Primary aldosteronism. Hypertension 74, 458\u2013466 (2019).","journal-title":"Hypertension"},{"key":"3715_CR2","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1038\/nrneph.2013.110","volume":"9","author":"NJ Brown","year":"2013","unstructured":"Brown, N. J. Contribution of aldosterone to cardiovascular and renal inflammation and fibrosis. Nat. Rev. Nephrol. 9, 459\u2013469 (2013).","journal-title":"Nat. Rev. Nephrol."},{"key":"3715_CR3","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1080\/0886022X.2019.1662439","volume":"41","author":"P Kiatpanabhikul","year":"2019","unstructured":"Kiatpanabhikul, P. & Bunyayothin, W. Uncommon presentation of primary hyperaldosteronism with severe hypomagnesemia: A Gitelman syndrome mimic. Ren. Fail 41, 862\u2013865 (2019).","journal-title":"Ren. Fail"},{"key":"3715_CR4","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1038\/jhh.2012.22","volume":"27","author":"AD Rao","year":"2013","unstructured":"Rao, A. D. et al. Polymorphisms in the serum- and glucocorticoid-inducible kinase 1 gene are associated with blood pressure and renin response to dietary salt intake. J. Hum. Hypertens. 27, 176\u2013180 (2013).","journal-title":"J. Hum. Hypertens."},{"key":"3715_CR5","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1093\/ajh\/hpy120","volume":"31","author":"M Buonafine","year":"2018","unstructured":"Buonafine, M., Bonnard, B. & Jaisser, F. Mineralocorticoid receptor and cardiovascular disease. Am. J. Hypertens. 31, 1165\u20131174 (2018).","journal-title":"Am. J. Hypertens."},{"key":"3715_CR6","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1161\/01.HYP.35.1.113","volume":"35","author":"P Delva","year":"2000","unstructured":"Delva, P. et al. Intralymphocyte free magnesium in patients with primary aldosteronism: Aldosterone and lymphocyte magnesium homeostasis. Hypertension 35, 113\u2013117 (2000).","journal-title":"Hypertension"},{"key":"3715_CR7","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1038\/ki.2014.331","volume":"87","author":"A Tin","year":"2015","unstructured":"Tin, A. et al. Results from the Atherosclerosis Risk in Communities study suggest that low serum magnesium is associated with incident kidney disease. Kidney Int. 87, 820\u2013827 (2015).","journal-title":"Kidney Int."},{"key":"3715_CR8","doi-asserted-by":"publisher","first-page":"e17069","DOI":"10.1097\/MD.0000000000017069","volume":"98","author":"T Nishihara","year":"2019","unstructured":"Nishihara, T. et al. Clinical significance of serum magnesium levels in patients with heart failure with preserved ejection fraction. Medicine 98, e17069 (2019).","journal-title":"Medicine"},{"key":"3715_CR9","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1161\/01.CIR.0000155621.10213.06","volume":"111","author":"VS Chhokar","year":"2005","unstructured":"Chhokar, V. S. et al. Hyperparathyroidism and the calcium paradox of aldosteronism. Circulation 111, 871\u2013878 (2005).","journal-title":"Circulation"},{"key":"3715_CR10","first-page":"86","volume":"19","author":"GS Stergiou","year":"1993","unstructured":"Stergiou, G. S., Mayopoulou-Symvoulidou, D. & Mountokalakis, T. D. Attenuation by spironolactone of the magnesiuric effect of acute frusemide administration in patients with liver cirrhosis and ascites. Min. Electrolyte Metab. 19, 86\u201390 (1993).","journal-title":"Min. Electrolyte Metab."},{"key":"3715_CR11","doi-asserted-by":"publisher","first-page":"F1027","DOI":"10.1152\/ajprenal.00634.2017","volume":"314","author":"OJM Schaffers","year":"2018","unstructured":"Schaffers, O. J. M., Hoenderop, J. G. J., Bindels, R. J. M. & de Baaij, J. H. F. The rise and fall of novel renal magnesium transporters. Am. J. Physiol. Ren. Physiol. 314, F1027\u2013F1033 (2018).","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"3715_CR12","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/112_2018_15","volume":"176","author":"M Kolisek","year":"2019","unstructured":"Kolisek, M. et al. Magnesium extravaganza: A critical compendium of current research into cellular Mg(2+) transporters other than TRPM6\/7. Rev. Physiol. Biochem. Pharm. 176, 65\u2013105 (2019).","journal-title":"Rev. Physiol. Biochem. Pharm."},{"key":"3715_CR13","doi-asserted-by":"publisher","first-page":"4706","DOI":"10.1073\/pnas.1810633116","volume":"116","author":"L Mittermeier","year":"2019","unstructured":"Mittermeier, L. et al. TRPM7 is the central gatekeeper of intestinal mineral absorption essential for postnatal survival. Proc. Natl Acad. Sci. USA 116, 4706\u20134715 (2019).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"3715_CR14","doi-asserted-by":"publisher","first-page":"2894","DOI":"10.1073\/pnas.0305252101","volume":"101","author":"V Chubanov","year":"2004","unstructured":"Chubanov, V. et al. Disruption of TRPM6\/TRPM7 complex formation by a mutation in the TRPM6 gene causes hypomagnesemia with secondary hypocalcemia. Proc. Natl Acad. Sci. USA 101, 2894\u20132899 (2004).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"3715_CR15","doi-asserted-by":"publisher","first-page":"R73","DOI":"10.1152\/ajpregu.00515.2005","volume":"290","author":"RM Touyz","year":"2006","unstructured":"Touyz, R. M. et al. Differential regulation of transient receptor potential melastatin 6 and 7 cation channels by ANG II in vascular smooth muscle cells from spontaneously hypertensive rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 290, R73\u2013R78 (2006).","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"3715_CR16","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1097\/HJH.0b013e3283190582","volume":"27","author":"GE Callera","year":"2009","unstructured":"Callera, G. E. et al. Regulation of the novel Mg2+ transporter transient receptor potential melastatin 7 (TRPM7) cation channel by bradykinin in vascular smooth muscle cells. J. Hypertens. 27, 155\u2013166 (2009).","journal-title":"J. Hypertens."},{"key":"3715_CR17","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1161\/01.RES.0000152967.88472.3e","volume":"96","author":"Y He","year":"2005","unstructured":"He, Y., Yao, G., Savoia, C. & Touyz, R. M. Transient receptor potential melastatin 7 ion channels regulate magnesium homeostasis in vascular smooth muscle cells: Role of angiotensin II. Circ. Res. 96, 207\u2013215 (2005).","journal-title":"Circ. Res."},{"key":"3715_CR18","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.1161\/ATVBAHA.117.309161","volume":"37","author":"K Zhang","year":"2017","unstructured":"Zhang, K. et al. Interleukin-18 enhances vascular calcification and osteogenic differentiation of vascular smooth muscle cells through TRPM7 activation. Arteriosclerosis, Thrombosis, Vasc. Biol. 37, 1933\u20131943 (2017).","journal-title":"Arteriosclerosis, Thrombosis, Vasc. Biol."},{"key":"3715_CR19","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1097\/HJH.0b013e32834786d6","volume":"29","author":"A Yogi","year":"2011","unstructured":"Yogi, A. et al. Dysregulation of renal transient receptor potential melastatin 6\/7 but not paracellin-1 in aldosterone-induced hypertension and kidney damage in a model of hereditary hypomagnesemia. J. Hypertens. 29, 1400\u20131410 (2011).","journal-title":"J. Hypertens."},{"key":"3715_CR20","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1253\/circj.CJ-10-1021","volume":"75","author":"A Yogi","year":"2011","unstructured":"Yogi, A., Callera, G. E., Antunes, T. T., Tostes, R. C. & Touyz, R. M. Transient receptor potential melastatin 7 (TRPM7) cation channels, magnesium and the vascular system in hypertension. Circ. J. 75, 237\u2013245 (2011).","journal-title":"Circ. J."},{"key":"3715_CR21","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.pharmthera.2017.11.003","volume":"184","author":"V Chubanov","year":"2018","unstructured":"Chubanov, V., Mittermeier, L. & Gudermann, T. Role of kinase-coupled TRP channels in mineral homeostasis. Pharm. Ther. 184, 159\u2013176 (2018).","journal-title":"Pharm. Ther."},{"key":"3715_CR22","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/S0092-8674(03)00556-7","volume":"114","author":"C Schmitz","year":"2003","unstructured":"Schmitz, C. et al. Regulation of vertebrate cellular Mg2+ homeostasis by TRPM7. Cell 114, 191\u2013200 (2003).","journal-title":"Cell"},{"key":"3715_CR23","doi-asserted-by":"publisher","first-page":"20793","DOI":"10.1074\/jbc.M413671200","volume":"280","author":"M Matsushita","year":"2005","unstructured":"Matsushita, M. et al. Channel function is dissociated from the intrinsic kinase activity and autophosphorylation of TRPM7\/ChaK1. J. Biol. Chem. 280, 20793\u201320803 (2005).","journal-title":"J. Biol. Chem."},{"key":"3715_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms1108","volume":"1","author":"LV Ryazanova","year":"2010","unstructured":"Ryazanova, L. V. et al. TRPM7 is essential for Mg(2+) homeostasis in mammals. Nat. Commun. 1, 109 (2010).","journal-title":"Nat. Commun."},{"key":"3715_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/srep05718","volume":"4","author":"T Kaitsuka","year":"2014","unstructured":"Kaitsuka, T. et al. Inactivation of TRPM7 kinase activity does not impair its channel function in mice. Sci. Rep. 4, 5718 (2014).","journal-title":"Sci. Rep."},{"key":"3715_CR26","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1161\/HYPERTENSIONAHA.107.100339","volume":"51","author":"B Sontia","year":"2008","unstructured":"Sontia, B., Montezano, A. C., Paravicini, T., Tabet, F. & Touyz, R. M. Downregulation of renal TRPM7 and increased inflammation and fibrosis in aldosterone-infused mice: effects of magnesium. Hypertension 51, 915\u2013921 (2008).","journal-title":"Hypertension"},{"key":"3715_CR27","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1016\/j.cellsig.2013.07.002","volume":"25","author":"A Yogi","year":"2013","unstructured":"Yogi, A. et al. Aldosterone signaling through transient receptor potential melastatin 7 cation channel (TRPM7) and its alpha-kinase domain. Cell. Signal. 25, 2163\u20132175 (2013).","journal-title":"Cell. Signal."},{"key":"3715_CR28","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvz164","author":"FJ Rios","year":"2019","unstructured":"Rios, F. J. et al. Chanzyme TRPM7 protects against cardiovascular inflammation and fibrosis. Cardiovasc. Res. https:\/\/doi.org\/10.1093\/cvr\/cvz164 (2019).","journal-title":"Cardiovasc. Res."},{"key":"3715_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms11097","volume":"7","author":"S Stritt","year":"2016","unstructured":"Stritt, S. et al. Defects in TRPM7 channel function deregulate thrombopoiesis through altered cellular Mg(2+) homeostasis and cytoskeletal architecture. Nat. Commun. 7, 11097 (2016).","journal-title":"Nat. Commun."},{"key":"3715_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-01960-z","volume":"8","author":"A Romagnani","year":"2017","unstructured":"Romagnani, A. et al. TRPM7 kinase activity is essential for T cell colonization and alloreactivity in the gut. Nat. Commun. 8, 1917 (2017).","journal-title":"Nat. Commun."},{"key":"3715_CR31","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1016\/j.cell.2006.03.044","volume":"125","author":"X Lin","year":"2006","unstructured":"Lin, X. et al. PPM1A functions as a Smad phosphatase to terminate TGFbeta signaling. Cell 125, 915\u2013928 (2006).","journal-title":"Cell"},{"key":"3715_CR32","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/j.bbrc.2019.11.112","volume":"522","author":"B Lee","year":"2020","unstructured":"Lee, B. et al. Protein phosphatase magnesium-dependent 1A induces inflammation in rheumatoid arthritis. Biochem. Biophys. Res. Commun. 522, 731\u2013735 (2020).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"3715_CR33","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s12011-019-01750-2","volume":"192","author":"S Wang","year":"2019","unstructured":"Wang, S. et al. The functional analysis of selenium-related genes and magnesium-related genes in the gene expression profile microarray in the peripheral blood mononuclear cells of Keshan disease. Biol. Trace Elem. Res. 192, 3\u20139 (2019).","journal-title":"Biol. Trace Elem. Res."},{"key":"3715_CR34","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1161\/CIRCULATIONAHA.114.011079","volume":"131","author":"QD Zhao","year":"2015","unstructured":"Zhao, Q. D. et al. NADPH oxidase 4 induces cardiac fibrosis and hypertrophy through activating Akt\/mTOR and NFkappaB signaling pathways. Circulation 131, 643\u2013655 (2015).","journal-title":"Circulation"},{"key":"3715_CR35","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.metabol.2013.08.016","volume":"63","author":"A Tomaschitz","year":"2014","unstructured":"Tomaschitz, A. et al. Aldosterone and parathyroid hormone interactions as mediators of metabolic and cardiovascular disease. Metabolism 63, 20\u201331 (2014).","journal-title":"Metabolism"},{"key":"3715_CR36","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1016\/0002-9343(55)90164-9","volume":"19","author":"IJ Mader","year":"1955","unstructured":"Mader, I. J. & Iseri, L. T. Spontaneous hypopotassemia, hypomagnesemia, alkalosis and tetany due to hypersecretion of corticosterone-like mineralocorticoid. Am. J. Med. 19, 976\u2013988 (1955).","journal-title":"Am. J. Med."},{"key":"3715_CR37","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1210\/jcem-22-12-1187","volume":"22","author":"R Horton","year":"1962","unstructured":"Horton, R. & Biglieri, E. G. Effect of aldosterone on the metabolism of magnesium. J. Clin. Endocrinol. Metab. 22, 1187\u20131192 (1962).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"3715_CR38","doi-asserted-by":"publisher","first-page":"e13843","DOI":"10.14814\/phy2.13843","volume":"6","author":"H Mayan","year":"2018","unstructured":"Mayan, H., Farfel, Z. & Karlish, S. J. D. Renal Mg handling, FXYD2 and the central role of the Na,K-ATPase. Physiol. Rep. 6, e13843 (2018).","journal-title":"Physiol. Rep."},{"key":"3715_CR39","first-page":"432","volume":"122","author":"A Ichihara","year":"1993","unstructured":"Ichihara, A., Suzuki, H. & Saruta, T. Effects of magnesium on the renin-angiotensin-aldosterone system in human subjects. J. Lab Clin. Med. 122, 432\u2013440 (1993).","journal-title":"J. Lab Clin. Med."},{"key":"3715_CR40","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1016\/0024-3205(89)90327-5","volume":"44","author":"K Atarashi","year":"1989","unstructured":"Atarashi, K., Matsuoka, H., Takagi, M. & Sugimoto, T. Magnesium ion: A possible physiological regulator of aldosterone production. Life Sci. 44, 1483\u20131489 (1989).","journal-title":"Life Sci."},{"key":"3715_CR41","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1097\/01.mnh.0000447023.59346.ab","volume":"23","author":"J van der Wijst","year":"2014","unstructured":"van der Wijst, J., Bindels, R. J. & Hoenderop, J. G. Mg2+ homeostasis: The balancing act of TRPM6. Curr. Opin. Nephrol. Hypertens. 23, 361\u2013369 (2014).","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"3715_CR42","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1111\/j.1440-1681.2005.04161.x","volume":"32","author":"K Matsumura","year":"2005","unstructured":"Matsumura, K., Fujii, K., Kansui, Y., Arima, H. & Iida, M. Prolongation of the QT interval in primary aldosteronism. Clin. Exp. Pharm. Physiol. 32, 66\u201369 (2005).","journal-title":"Clin. Exp. Pharm. Physiol."},{"key":"3715_CR43","doi-asserted-by":"publisher","first-page":"2459","DOI":"10.1097\/01.hjh.0000251908.93298.a0","volume":"24","author":"S Maule","year":"2006","unstructured":"Maule, S. et al. QT interval in patients with primary aldosteronism and low-renin essential hypertension. J. Hypertens. 24, 2459\u20132464 (2006).","journal-title":"J. Hypertens."},{"key":"3715_CR44","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1161\/HYPERTENSIONAHA.115.07021","volume":"67","author":"TT Antunes","year":"2016","unstructured":"Antunes, T. T. et al. Transient receptor potential melastatin 7 cation channel kinase: New player in angiotensin II-induced hypertension. Hypertension 67, 763\u2013773 (2016).","journal-title":"Hypertension"},{"key":"3715_CR45","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.ceca.2017.03.004","volume":"67","author":"V Chubanov","year":"2017","unstructured":"Chubanov, V., Ferioli, S. & Gudermann, T. Assessment of TRPM7 functions by drug-like small molecules. Cell Calcium 67, 166\u2013173 (2017).","journal-title":"Cell Calcium"},{"key":"3715_CR46","first-page":"308","volume":"5","author":"MD Garcia","year":"2014","unstructured":"Garcia, M. D. & Larina, I. V. Vascular development and hemodynamic force in the mouse yolk sac. Front. Physiol. 5, 308 (2014).","journal-title":"Front. Physiol."},{"key":"3715_CR47","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1016\/j.bbrc.2017.10.122","volume":"494","author":"M Yang","year":"2017","unstructured":"Yang, M., Fang, J., Liu, Q., Wang, Y. & Zhang, Z. Role of ROS-TRPM7-ERK1\/2 axis in high concentration glucose-mediated proliferation and phenotype switching of rat aortic vascular smooth muscle cells. Biochem. Biophys. Res. Commun. 494, 526\u2013533 (2017).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"3715_CR48","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1016\/j.devcel.2012.04.006","volume":"22","author":"BN Desai","year":"2012","unstructured":"Desai, B. N. et al. Cleavage of TRPM7 releases the kinase domain from the ion channel and regulates its participation in Fas-induced apoptosis. Dev. Cell 22, 1149\u20131162 (2012).","journal-title":"Dev. Cell"},{"key":"3715_CR49","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1161\/HYPERTENSIONAHA.118.11065","volume":"72","author":"G Jia","year":"2018","unstructured":"Jia, G., Aroor, A. R., Hill, M. A. & Sowers, J. R. Role of renin-angiotensin-aldosterone system activation in promoting cardiovascular fibrosis and stiffness. Hypertension 72, 537\u2013548 (2018).","journal-title":"Hypertension"},{"key":"3715_CR50","doi-asserted-by":"publisher","first-page":"2641","DOI":"10.1096\/fj.201902015RR","volume":"34","author":"J Tang","year":"2020","unstructured":"Tang, J., Goldschmeding, R., Samarakoon, R. & Higgins, P. J. Protein phosphatase Mg(2+)\/Mn(2+) dependent-1A and PTEN deregulation in renal fibrosis: Novel mechanisms and co-dependency of expression. FASEB J. 34, 2641\u20132656 (2020).","journal-title":"FASEB J."},{"key":"3715_CR51","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1093\/cvr\/cvx204","volume":"114","author":"M Zhang","year":"2018","unstructured":"Zhang, M. et al. Both cardiomyocyte and endothelial cell Nox4 mediate protection against hemodynamic overload-induced remodelling. Cardiovasc. Res. 114, 401\u2013408 (2018).","journal-title":"Cardiovasc. Res."},{"key":"3715_CR52","doi-asserted-by":"publisher","first-page":"e3000411","DOI":"10.1371\/journal.pbio.3000411","volume":"18","author":"N Percie du Sert","year":"2020","unstructured":"Percie du Sert, N. et al. Reporting animal research: Explanation and elaboration for the ARRIVE guidelines 2.0. PLoS Biol. 18, e3000411 (2020).","journal-title":"PLoS Biol."},{"key":"3715_CR53","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1161\/HYPERTENSIONAHA.121.17041","volume":"78","author":"R Alves-Lopes","year":"2021","unstructured":"Alves-Lopes, R. et al. Selective inhibition of the C-Domain of ACE (Angiotensin-Converting Enzyme) combined with inhibition of NEP (Neprilysin): A potential new therapy for hypertension. Hypertension 78, 604\u2013616 (2021).","journal-title":"Hypertension"},{"key":"3715_CR54","doi-asserted-by":"publisher","first-page":"H193","DOI":"10.1152\/ajpheart.00802.2005","volume":"291","author":"AM Briones","year":"2006","unstructured":"Briones, A. M. et al. Alterations in structure and mechanics of resistance arteries from ouabain-induced hypertensive rats. Am. J. Physiol. Heart Circ. Physiol. 291, H193\u2013H201 (2006).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"3715_CR55","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1161\/01.HYP.13.6.968","volume":"13","author":"GL Baumbach","year":"1989","unstructured":"Baumbach, G. L. & Heistad, D. D. Remodeling of cerebral arterioles in chronic hypertension. Hypertension 13, 968\u2013972 (1989).","journal-title":"Hypertension"},{"key":"3715_CR56","doi-asserted-by":"publisher","first-page":"e1004267","DOI":"10.1371\/journal.pgen.1004267","volume":"10","author":"FJ Arjona","year":"2014","unstructured":"Arjona, F. J. et al. CNNM2 mutations cause impaired brain development and seizures in patients with hypomagnesemia. PLoS Genet. 10, e1004267 (2014).","journal-title":"PLoS Genet."},{"key":"3715_CR57","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak, K. J. & Schmittgen, T. D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25, 402\u2013408 (2001).","journal-title":"Methods"}],"container-title":["Communications Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s42003-022-03715-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-022-03715-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-022-03715-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T08:54:42Z","timestamp":1669366482000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s42003-022-03715-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,26]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["3715"],"URL":"https:\/\/doi.org\/10.1038\/s42003-022-03715-z","relation":{},"ISSN":["2399-3642"],"issn-type":[{"value":"2399-3642","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,26]]},"assertion":[{"value":"1 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"746"}}